Company news

Vericel Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

October 24, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

September 27, 2023

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

September 19, 2023

Vericel to Present at the Morgan Stanley Global Healthcare Conference

September 5, 2023

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

August 1, 2023

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

July 19, 2023

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

May 9, 2023

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

April 25, 2023

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

February 27, 2023

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

February 22, 2023

Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023

February 8, 2023

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

January 9, 2023

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

January 3, 2023

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

December 28, 2022

Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference

November 9, 2022

Vericel Reports Third Quarter 2022 Financial Results

November 8, 2022

Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022

October 25, 2022

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

September 21, 2022

Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences

September 5, 2022

Vericel Reports Second Quarter 2022 Financial Results

August 2, 2022

Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

July 20, 2022

Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

July 19, 2022

Vericel Reports First Quarter 2022 Financial Results

May 3, 2022

Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022

April 19, 2022

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022

March 14, 2022

Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022

February 28, 2022

Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

February 23, 2022

Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer

February 23, 2022

Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022

February 9, 2022

Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth

February 1, 2022

Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

January 3, 2022

Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021

November 10, 2021

Vericel Reports Third Quarter 2021 Financial Results

November 8, 2021

Vericel to Report Third-Quarter 2021 Financial Results on November 9, 2021

October 20, 2021

Vericel to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13th, 2021

September 7, 2021

Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy

September 6, 2021

Vericel Reports Second Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance

August 3, 2021

Vericel to Report Second-Quarter 2021 Financial Results on August 4, 2021

July 20, 2021

Vericel to Present at the Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021

July 6, 2021

Vericel Provides Regulatory Update for NexoBrid

June 28, 2021

Vericel to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021

June 8, 2021

Vericel Announces Appointment of Lisa Wright to Board of Directors

June 1, 2021

Vericel to Present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20, 2021

May 12, 2021

Vericel Reports First Quarter 2021 Financial Results and Raises Full-Year 2021 Revenue Guidance

May 4, 2021

Vericel to Report First-Quarter 2021 Financial Results on May 5, 2021

April 20, 2021

Vericel to Present at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021

April 8, 2021

Vericel to Present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021

March 9, 2021

Vericel Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Life Sciences Conference

March 1, 2021

Vericel Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Full-Year 2021 Financial Guidance

February 23, 2021

Vericel to Present at the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021

February 21, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 34 decks. Every deck is listed under its year.